Navigation Links
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
Date:8/5/2009

DUBLIN, August 5 /PRNewswire-FirstCall/ --

- 2009 Guidance Framework Reaffirmed

Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to June 30, 2009.

    Q2 2009 Financial Highlights

                                                             Q2 2009(1)

    Product sales                                  $558 million        -21%

    Product sales (excluding ADDERALL XR)          $491 million        +20%
    Product sales growth (excluding ADDERALL XR) at
    constant exchange rates(2)                                         +27%

    Non GAAP operating income                      $116 million        -53%

    US GAAP operating income                        $35 million +$102 million
    Non GAAP diluted earnings per ADS (using actual Q2
    2009 tax rate: 2%)                                    $0.60        -36%
    Non GAAP diluted earnings per ADS (using full year
    expected tax rate: 24%)                               $0.47
    US GAAP diluted earnings per ADS                      $0.24     +$0.68


    (1) Figures compare Q2 2009 results with the same period in 2008.

(2) Sales growth at constant exchange rates ("CER"), which is a Non GAAP measure, is calculated after restating Q2 2009 results using Q2 2008 average foreign exchange rates.

Angus Russell, Chief Executive Officer, commented:

"In the second quarter we delivered strong core product sales, excluding ADDERALL XR, of $491 million, representing growth of 20% compared to the same quarter last year. The strategic steps we have taken over the last few years are now delivering clear commercial benefits, as we enter a new phase of Shire's development.

We have diversified into a broader portfolio of young pro
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology
2. The Crohns & Colitis Foundation of America and Shire Launch Virtual IBD March on the Hill to Increase Funding for Digestive Disease Research
3. Shire begins the year with a strong performance
4. Shire plc: Results of the Annual General Meeting Held on April 28, 2009
5. Shire plc: First Quarter 2009 Results Date Notification - April 30, 2009
6. Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents
7. Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
8. Publication of Shire plcs Annual Report 2008
9. Shires Project Playground Gives Boost to Philadelphia
10. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
11. Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & ... & Auto Injectors] & Therapeutics [Diabetes & ... report to their offering.      ...
(Date:6/18/2013)... AZ (PRWEB) June 18, 2013 ... services MeMD, Inc proudly announces the release of ... Health and Fitness ". , MeMD's goal was ... ever-changing landscape of Health 2.0, Health 3.0 and ... will likely transform medical care and the fitness ...
(Date:6/18/2013)... WA (PRWEB) June 18, 2013 Though ... -- 11,000, according to the U.S. Bureau of Labor Statistics ... increase of 24,000 per month. Most new health care jobs ... the hospital sector saw a loss of 6,000 jobs. Overall, ... outplacement consultancy firm Challenger, Gray & Christmas reported that a ...
(Date:6/18/2013)... Minneapolis, MN (PRWEB) June 18, 2013 ... the Saniclave 200 prevent the dangers of ... confusing features, like knobs, analog pressure gauges, hot surfaces ... older autoclave, or a new, modern autoclave, Revolutionary Science ... use fresh water. Older autoclave designs will recycle ...
Breaking Biology Technology:Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2
... Timely Hearing before a NASDAQ Listing ... Qualifications Panel -, ... VRMLD) (the "Company"), a molecular diagnostics company,announced today that on March ... that, as a result of the Company,s,common stock closing at $1.00 ...
... Corp. (Nasdaq: MEMY ) today reported that ... explanatory,paragraph in their opinion on the Company,s financial ... Form 10-K for the year ended,December 31, 2007, ... a going,concern. The Company discusses this matter, including ...
... Organization,s National Networking ... And Expo ... (DA4S) (http://www.diversityallianceforscience.com ) has announced,that Merck & Co., Inc. will ... scheduled for May 19-20 at the Westin,Governors in Morristown, N.J. The ...
Cached Biology Technology:Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization 2Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization 3Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization 4Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification 2Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Science's Inaugural Conference 2
(Date:6/17/2013)... of mining shale gas, is widespread across Pennsylvania, covering ... research in the Annals of the New York ... biodiversity including pollution from toxic chemicals, the building of ... "Shale gas has engendered a great deal of controversy, ... effects on biological diversity and resources have scarcely been ...
(Date:6/16/2013)... female sex workers in India reduce rates of syphilis, ... of Toronto study has found. , About ... the southern states of Andhra Pradesh, Karnataka, Maharashtra and ... from U of T,s Dalla Lana School of Public ... Research (CGHR), examined the impact of prevention among female ...
(Date:6/16/2013)... and move around the body called ,chase and run, ... at UCL. , Published in Nature Cell Biology ... when cancer cells interact with healthy cells in order to ... cells recruit healthy cells and use them to travel long ... could be controlled to design new therapies against cancer remains ...
Breaking Biology News(10 mins):HIV prevention among female sex workers in India reduces HIV and syphilis 2'Chase and run' cell movement mechanism explains process of metastasis 2
... scientists to track the habitat preferences and movements of ... managers protect overfished species such as red snapper and ... current online edition of the peer-reviewed Bulletin of ... exactly what areas to protect," says Matt Kendall, principle ...
... Results of the first study evaluating the use of human ... crops has found that the combination can be substituted for ... introducing any risk of disease for consumers. The study appears ... and Food Chemistry , a bi-weekly publication. In ...
... regulate the energy consumption of cells have a different structure ... healthy people, according to a new study from the Swedish ... The researchers believe that these ,epigenetic mutations, might have a ... Type II diabetes is characterised by a lower ...
Cached Biology News:NOAA scientists map fish habitat and movements at Gray's Reef Marine Sanctuary 2
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
Biology Products: